BioMotiv LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BioMotiv LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11192
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioMotiv LLC (BioMotiv) is a therapeutics licensing and development service provider. The company offers therapeutics across wide disease areas including proteins, small molecules, antibodies, and nucleotides. It portfolio includes psoriasis, inflammatory bowel diseases, cancer, retinitis pigmentosa, anti-inflammatory, inflammatory diseases, chronic obstructive pulmonary disease, immuno-oncology and acute kidney injury, among others. BioMotiv serves inventors, investors, patients and physicians, among others. The company partners with harrington discovery institute, universities and research institutions, disease foundations, and industry sources. It offers research and development, and pre clinical services. BioMotiv is headquartered in Cleveland, Ohio, the US.

BioMotiv LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioMotiv LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioMotiv LLC, Medical Devices Deals, 2012 to YTD 2018 9
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioMotiv LLC, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Allinaire Therapeutics Raises Funds in Seed Financing 12
Allinaire Therapeutics Raises USD1 Million in Venture financing 13
BioMotiv Raises Additional USD30.5 Million in Venture Financing 14
BioMotiv Raises Additional USD4.8 Million in Venture Financing 15
Orca Pharma Raises USD1.3 Million in Venture Financing 16
Orca Pharma Raises Funds through Venture Financing 17
BioMotiv Raises US$25 Million In Venture Financing 18
BioMotiv Raises US$21 Million In Series A Financing 19
BioMotiv Raises Additional USD1 Million in Venture Financing 20
Partnerships 21
Charles River Labs Enters into Agreement with BioMotiv 21
BioMotiv Forms Joint Venture with Rutgers University 22
BioMotiv Expands its Agreement with Biogen 23
BioMotiv, University of California San Francisco and University of Washington Center for Commercialization Form Joint Venture 24
Licensing Agreements 25
BioAtla Enters Into Licensing Agreement With BioMotiv 25
Sujana Biotech Enters into Licensing Agreement with Case Western Reserve University 26
Equity Offering 27
BioMotiv to Raise up to USD25 Million in Private Placement of Shares 27
Charles River Labs to Invest USD10 Million in BioMotiv 28
Acquisition 29
Takeda Pharma Acquires Minority Stake in BioMotiv for USD25 Million 29
BioMotiv LLC – Key Competitors 30
BioMotiv LLC – Key Employees 31
BioMotiv LLC – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Joint Venture 33
Recent Developments 34
Strategy And Business Planning 34
Mar 16, 2017: Nynex Therapeutics Launched to Target Oncogenic Proteins in the Treatment of Cancer 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
BioMotiv LLC, Pharmaceuticals & Healthcare, Key Facts 2
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioMotiv LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioMotiv LLC, Deals By Therapy Area, 2012 to YTD 2018 8
BioMotiv LLC, Medical Devices Deals, 2012 to YTD 2018 9
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Allinaire Therapeutics Raises Funds in Seed Financing 12
Allinaire Therapeutics Raises USD1 Million in Venture financing 13
BioMotiv Raises Additional USD30.5 Million in Venture Financing 14
BioMotiv Raises Additional USD4.8 Million in Venture Financing 15
Orca Pharma Raises USD1.3 Million in Venture Financing 16
Orca Pharma Raises Funds through Venture Financing 17
BioMotiv Raises US$25 Million In Venture Financing 18
BioMotiv Raises US$21 Million In Series A Financing 19
BioMotiv Raises Additional USD1 Million in Venture Financing 20
Charles River Labs Enters into Agreement with BioMotiv 21
BioMotiv Forms Joint Venture with Rutgers University 22
BioMotiv Expands its Agreement with Biogen 23
BioMotiv, University of California San Francisco and University of Washington Center for Commercialization Form Joint Venture 24
BioAtla Enters Into Licensing Agreement With BioMotiv 25
Sujana Biotech Enters into Licensing Agreement with Case Western Reserve University 26
BioMotiv to Raise up to USD25 Million in Private Placement of Shares 27
Charles River Labs to Invest USD10 Million in BioMotiv 28
Takeda Pharma Acquires Minority Stake in BioMotiv for USD25 Million 29
BioMotiv LLC, Key Competitors 30
BioMotiv LLC, Key Employees 31
BioMotiv LLC, Other Locations 32
BioMotiv LLC, Subsidiaries 32
BioMotiv LLC, Joint Venture 33

List of Figures
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioMotiv LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[BioMotiv LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lipocine Inc (LPCN):企業の財務・戦略的SWOT分析
    Summary Lipocine Inc (Lipocine) operates as a pharmaceutical company that develops and commercializes treatment for men's and women's health. The company’s pipeline products for men’s health include LPCN 1111 and LPCN 1021; and for women’s health include LPCN 1107. Its LPCN 1111 is an oral testoster …
  • Kootenai Electric Cooperative Inc:企業の戦略的SWOT分析
    Kootenai Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Binggrae Co., Ltd.:企業の戦略・SWOT・財務情報
    Binggrae Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Binggrae Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nutricia GmbH:企業の戦略的SWOT分析
    Nutricia GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Itau Unibanco Holding SA:企業の戦略・SWOT・財務情報
    Itau Unibanco Holding SA - Strategy, SWOT and Corporate Finance Report Summary Itau Unibanco Holding SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Echelon Corporation:企業の戦略的SWOT分析
    Echelon Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Thai Beverage Public Company Limited:戦略・SWOT・企業財務分析
    Thai Beverage Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thai Beverage Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Rio Grande Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Rio Grande Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Tokyo Electric Power Company Holdings Incorporated (9501):電力:M&Aディール及び事業提携情報
    Summary Tokyo Electric Power Company Holdings Incorporated (TEPCO) is an energy utility. It generates, transmits and distributes electricity; transports fuel; and retails electricity and gas. The company produces power using coal, gas, LNG, solar, wind and hydro sources. TEPCO has presence in the en …
  • Gulfslope Energy Inc (GSPE):石油・ガス:M&Aディール及び事業提携情報
    Summary Gulfslope Energy Inc (Gulfslope Energy), formerly Plan A Promotions Inc, is an oil and gas company. The company’s business activities include acquisition, exploration, development, and production of crude oil and natural gas. It utilizes 3D seismic data to identify high quality exploration p …
  • PDC Energy Inc (PDCE):石油・ガス:M&Aディール及び事業提携情報
    Summary PDC Energy Inc (PDC Energy) is an oil and gas company that offers production, development, exploration and marketing of crude oil, natural gas and natural gas liquids. The company provides horizontal drilling and low-risk organic development of oil and natural gas reserves from shales and ti …
  • Koninklijke Philips N.V. (PHIA)-エネルギー分野:企業M&A・提携分析
    Summary Koninklijke Philips N.V. (Philips) is a diversified technology company which focuses on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The company develops and manufactures medical …
  • Vertu Motors Plc:企業のM&A・事業提携・投資動向
    Vertu Motors Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vertu Motors Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Graftobian Makeup Company:企業の戦略・SWOT・財務情報
    Graftobian Makeup Company - Strategy, SWOT and Corporate Finance Report Summary Graftobian Makeup Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Ayala Corp (AC):企業の財務・戦略的SWOT分析
    Ayala Corp (AC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Mesa Air Group, Inc.:企業の戦略・SWOT・財務分析
    Mesa Air Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mesa Air Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • House Foods Group Inc:企業の戦略・SWOT・財務分析
    House Foods Group Inc - Strategy, SWOT and Corporate Finance Report Summary House Foods Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • HDFC Bank Ltd:戦略・SWOT・企業財務分析
    HDFC Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary HDFC Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Isagenix International LLC:企業の戦略的SWOT分析
    Isagenix International LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Corning Incorporated (GLW)-エネルギー分野:企業M&A・提携分析
    Summary Corning Incorporated (Corning) manufactures and sells ceramics, specialty glasses and related materials. The company’s product portfolio includes glass substrates, which find application in LCD televisions, computer monitors and laptops; optical fibers, cable, hardware and equipment for tele …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆